New head and neck cancer drug could help patients live longer
by Press Association from on (#4GEG9)
Pembrolizumab with platinum chemotherapy less 'aggressive' and extended survival rates
Immunotherapy could help patients with head and neck cancer live longer, new research suggests.
The drug pembrolizumab, used in combination with platinum chemotherapy, was found to extend survival among those whose disease had returned or spread, according to a study presented at the American Society of Clinical Oncology annual meeting in Chicago.
Continue reading...